Before you sell to, join or invest in REVI LIFE SCIENCES, INC.
MentionFox check on REVI LIFE SCIENCES, INC.: only 2 sources on file so far (checked 4 November 2026). Run a full check before you rely on it. mentionfox.com/c/funding/revi-life-sciences-inc-form-d-25000001
Check REVI LIFE SCIENCES, INC. before you sell to, join or invest Free, no sign-up: every record on file, each linked to its source.
What do you want to do about REVI LIFE SCIENCES, INC.?
Based on the records MentionFox holds for this company. No flag is not a clearance.
REVI LIFE SCIENCES, INC. filed an amended Form D with the Securities and Exchange Commission on 2025-04-07.
REVI LIFE SCIENCES, INC. filed an amended Form D notice of an exempt securities offering with the SEC on April 7, 2025. The filing reports $340K sold. Its industry group is Biotechnology. It names Jason Eades (Executive Officer, Director) (SEC Form D/A, April 7, 2025).
Is this your company?
Sell to companies like REVI LIFE SCIENCES, INC? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-04-07 · the record
Pitching, partnering or investing alongside them? See who really runs and owns REVI LIFE SCIENCES, INC.
Free to see. No signup.
More on the people and the money behind REVI LIFE SCIENCES, INC., from the filings we hold.
Biotechnology raises by companies based in Texas, filed within 90 days of this one, largest first.
Get an email when REVI LIFE SCIENCES, INC. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when REVI LIFE SCIENCES, INC. raises, hires or launches. No email unless you switch it on.
Watch REVI LIFE SCIENCES, INC. →Get the full cited report on REVI LIFE SCIENCES, INC.
What the filing shows about REVI LIFE SCIENCES, INC.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on REVI LIFE SCIENCES, INC.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives REVI LIFE SCIENCES, INC.'s address as 6101 Highland Campus Dr, Bldg 4000, Ste 2250, Austin, TX 78752.
Saved here on this device in the meantime, so nothing is lost either way.
Amended on 2025-04-07: the amount sold changed from $40,000 to $340,000; the number of investors changed from 1 to 9. Figures on this page are from the amendment. Amended filing · Original filing
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Order the Full Report on REVI LIFE SCIENCES, INC. See pricing
REVI LIFE SCIENCES, INC. is a registered filer with the SEC (CIK 2037797) and has filed since 2025-04-07. 2 filings are on record, the latest on 2025-04-07.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
REVI LIFE SCIENCES, INC.'s Form D of 2025-04-07 names Jason Eades as its officers, directors or promoters.
Its new offerings report $40K sold across 1 offering, as its own filings state.
A hollow marker is an amendment (Form D/A); a solid one is an original Form D. The larger marker is the filing this page is about.
Trailing twelve months. 766 filings in Biotechnology, totalled by week.
Jason Eades is named as Executive Officer and Director on the Form D that REVI LIFE SCIENCES, INC. filed with the SEC on 7 April 2025, the only person that filing names.
1 person named on the filing — 1 holding an executive role.
Named as of the 2025-04-07 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
What the filing shows about REVI LIFE SCIENCES, INC.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on REVI LIFE SCIENCES, INC.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on REVI LIFE SCIENCES, INC. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist REVI LIFE SCIENCES, INC.You get an alert in MentionFox the next time this company shows up.
If you're behind REVI LIFE SCIENCES, INC.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for REVI LIFE SCIENCES, INC.. With no account yet, you sign up free and land on the result.
On these lists: Biotech raises in Austin
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/revi-life-sciences-inc-form-d-25000001